The efficacy of traditional Chinese medicine in the treatment of the COVID-19 pandemic in Henan Province: a retrospective study

Abstract

Background Since 2020, novel coronavirus disease (COVID-19) has posed serious threats to health systems and led to tremendous economic decline worldwide. Traditional Chinese medicine (TCM) is considered a promising treatment strategy for COVID-19 in China and is increasingly recognized as a key participant in the battle against COVID-19. Clinicians also need accurate evidence regarding the effectiveness of TCM treatments for COVID-19. Methods We retrospectively analyzed patients diagnosed with COVID-19 by collected from the electronic medical records of the hospitals in Henan Province from January 19, 2020, to March 2, 2020. Demographic characteristics, clinical data, frequency analysis of Chinese patent medicines (CPMs), Chinese medicine injections (CMIs), evaluation of baseline symptom scores, nucleic acid negative conversion, length of hospitalization, and mortality rates were studied. Results Between 15 January 2020 and 2 March 2020, 131 hospitals with 1245 patients were included. Survey response Chinese herbal decoction, CPMs, and CMIs combined with conventional Western medicine (CWM) used for the treatment of COVID-19. The top 8 CPMs were Lianhua Qingwen capsules, Shuanghuanglian oral liquid, Pudilan Xiaoyan oral liquid, Banlangen granules, Lanqin oral liquid, compound licorice tablets, Bailing capsules, montmorillonite powder. The most frequently used CMIs were Xuebijing, Tanreqing, Reduning, Xiyanping and Yanhuning. TCM combined with CWM improved the patients’ symptom scores for fever, cough, chest tightness, shortness of breath, and fatigue. Nucleic acid negative conversion occurred at11.55 ± 5.91 d and the average length of hospitalization was 14.92 ± 6.15 d. The mortality rate was approximately 1.76%, which is a reduction in patient mortality. Conclusions TCM combined with CWM improved clinical symptoms and reduced hospitalization and mortality rates.

Effect and mechanism of quercetin or quercetin‐containing formulas against COVID‐19: From bench to bedside

“…In the absence of strong direct evidence supporting the use of quercetin against COVID‐19, the current study explored indirect evidence by investigating the effectiveness of quercetin‐containing traditional Chinese medicine (TCM) formulas in alleviating COVID‐19 symptoms, which has been indicated by several retrospective clinical studies (Han et al, 2023; Wu et al, 2021). TCM formulas have been reported to be effective in alleviating symptoms such as fever, sweating, cough, headache, shortness of breath, chest distress, nausea, and diarrhea.…”

Research on Traditional Chinese Medicine Cultural Communication under the Background of "The Belt and Road"

“…TCM has been deeply involved in epidemic prevention and treatment. The release of TCM diagnosis and treatment plans for COVID-19 in multiple languages, the sharing of TCM anti-epidemic experience, the assistance of TCM experts in anti-epidemic, and the effective anti-epidemic TCM prescriptions of "three TCM drugs and three herbal formulas" have been learned and used by many countries [4]. While affirming the effectiveness of the current research, it also recognizes the lack of sufficient evidence for the efficacy of TCM overseas and the differences in TCM medical institutions abroad, which need to be further addressed.…”

Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry

“…The quest to curtail COVID-19's impact continues, as there is not a single FDA-approved treatment that can potentially prevent its spread or minimize its overall impact. Herbal medicine is an integral component of Traditional Chinese Medicine and was highly sought after to assist with minimizing the effects of the virus [14,15]. Dauricine and Isoliensinine are two common Traditional Chinese herbal compounds with numerous indications.…”